article thumbnail

Can Herbal Alternatives Ease the Economic Burden of Weight Loss Drugs?

MedCity News

For patients who may be unable to afford the high cost of GLP-1 obesity drugs or are worried about the side effects, it’s important for healthcare providers to offer education on herbal alternatives and consider these as part of the broader treatment conversation. appeared first on MedCity News.

article thumbnail

How AI can help healthcare providers with patient care management

Clarify Health

From enhancing diagnostic accuracy, to leveraging predictive analytics and developing personalized care plans, to supporting decision making and enhancing patient engagement, the use of AI in healthcare has many promising applications. This, in turn, strengthens market positioning, fosters patient trust, and helps to drive growth.

article thumbnail

Teva’s AUSTEDO XR Campaign Featured in MM+M

Eversana Intouch

AUSTEDO XR helps treat tardive dyskinesia (TD), a side effect of taking medications for mental illness. For pharma in general, it might be weeks or longer before you can even talk to your healthcare provider,” she says. “So MM+M recently named Teva Pharmaceuticals’ AUSTEDO XR campaign as their Campaign of the Week!

article thumbnail

Getting an Rx does not address health problems

World of DTC Marketing

There isn’t one method to get people exercising; it will take an approach for every healthcare provider to communicate the importance of exercise. Pharma websites provide the prescription that can help people overcome health problems but too often, they ignore the patient’s responsibility to lose weight and exercise.

Insurance 200
article thumbnail

The Role of ChatGPT in Enhancing Pharma Marketing Efficiency and Effectiveness

PM360

ChatGPT is poised to revolutionize the pharmaceutical industry by providing innovative communication and marketing strategies. Enriching Real-Time Communication AI-powered chatbots can help pharma marketers offer healthcare practitioners guidance on products and to make informed decisions about medications for their patients.

article thumbnail

New Prescription Migraine Drugs Aren’t Resonating with Patients—Here’s How Pharma Can Boost Uptake

PM360

However, the good news is that patients are asking their doctors for help—76% of surveyed patients reported having talked with their healthcare providers about migraine treatment options, and within that group, 64% and 54% discussed acute medications and preventive treatments, respectively. What Marketers Can Do. References: 1.

article thumbnail

The potential of virtual reality-based therapy for serious mental disorders

Pharmaceutical Technology

The FDA’s breakthrough device programme is for medical devices or device-led combination products that provide more effective treatment or diagnosis of diseases. The aim of the programme is to expedite the development, assessment and review of medical devices in order to provide timely access to patients and healthcare providers.